A new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time has been developed by researchers. This method identifies men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies. The new study by researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, published in the iJournal of Urology/i, shows that PSA can be a much more effective ...
via Medindia Health News
More READ
No comments:
Post a Comment